Metagenomi Therapeutics, Inc. - 10-Q Filing
Metagenomi Therapeutics, Inc. reports quarterly financial results for the period ending September 30, 2026.
Tickers: $MGX
Metagenomi Therapeutics, Inc. reports quarterly financial results for the period ending September 30, 2026.
Tickers: $MGX